Molecular MR imaging in oncology Journal Article
| Authors: | Bradbury, M.; Hricak, H. |
| Article Title: | Molecular MR imaging in oncology |
| Abstract: | The implementation and integration of systems biology approaches with the emerging nanosciences and microchip technology will revolutionize profoundly molecular imaging and fuel the drive toward a more predictive and individualized health care. In combination with informatics platforms, key gene and protein targets will be identified, and serve as more effective targets for diagnostic and therapeutic interventions. Drug development also will be expedited by the judicious selection of more appropriate molecular biomarkers that will serve as objective end points of treatment efficacy, in addition to facilitating the development of new target-specific therapeutics. Finally, with the more widespread proliferation of high-field magnets and advancements in imaging hardware; acquisition methods; and novel, "smart" MR agents, the ability to achieve higher resolution analyses of tumor biology, cell tracking, and gene expression will be realized more fully. Although radiologists will continue to serve as diagnostic consultants and assist in management decisions, the contributions from new developments in the biologic and molecular sciences will significantly alter the scope of our profession. Radiologists will be required to participate more actively in the individualized care of the patient and cultivate a deeper understanding of the underlying molecular basis of disease and molecular pharmacology for facilitating selection of the most appropriate combination of imaging studies that address biologically relevant questions. These radical changes in our profession will necessitate the re-education and emergence of a small cadre of professionals that is educated broadly in multiple scientific disciplines, and demonstrate expertise in clinical care and the basic sciences. The optimistic view is that this already is happening. © 2005 Elsevier Inc. All rights reserved. |
| Keywords: | vasculotropin; clinical trial; review; nonhuman; nuclear magnetic resonance imaging; magnetic resonance imaging; antineoplastic agent; diagnostic accuracy; clinical practice; neoplasms; biological markers; gene targeting; gene expression; tumor volume; protein targeting; tumor markers, biological; molecular imaging; oncology; cancer therapy; cancer invasion; image enhancement; gene therapy; nuclear magnetic resonance spectroscopy; contrast media; molecular biology; image processing, computer-assisted; parkinson disease; diffusion weighted imaging; perfusion weighted imaging; adoptive immunotherapy; tumor diagnosis; ultrasmall superparamagnetic iron oxide; nanotechnology; cytostatic agent; gadolinium pentetate meglumine; superparamagnetic iron oxide; medical informatics; cell based gene therapy; leg ischemia |
| Journal Title: | Magnetic Resonance Imaging Clinics of North America |
| Volume: | 13 |
| Issue: | 2 |
| ISSN: | 1064-9689 |
| Publisher: | W.B. Saunders Co-Elsevier Inc. |
| Date Published: | 2005-05-01 |
| Start Page: | 225 |
| End Page: | 240 |
| Language: | English |
| DOI: | 10.1016/j.mric.2005.03.008 |
| PUBMED: | 15935309 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 10" - "Export Date: 24 October 2012" - "CODEN: MRIAF" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work